8
total announcements
539470.BO · 15 min delayed
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has submitted its Annual Report for the financial year 2025-26, along with the Notice of 16th Annual General Meeting to be held on September 28, 2026.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has announced a book closure for its Annual General Meeting, from September 21 to September 28, 2026, for its equity shares listed on the BSE.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has submitted a notice of its 16th Annual General Meeting (AGM) to be held on 28th September 2026, where it will consider audited financial statements and re-appoint a director.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has updated its website and requested BSE and NSE to update their records with the new website URL (www.shreeganeshbiotech.bar).
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has informed that it does not have any unused funds from public issues, rights issues, or QIPs as of June 30, 2026.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 57.32 lakhs and a decline in revenue from operations to Rs. 142.99 lakhs.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net loss of Rs. 57.32 crores and a decline in revenue from operations.
Shree Ganesh Biotech (India) Ltd
Shree Ganesh Biotech (India) Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 04/08/2026 to consider and approve the Un-Audited Financial Results for the first quarter ended on 30th June 2026.